DocGo (DCGO) Competitors $1.65 +0.01 (+0.61%) Closing price 04:00 PM EasternExtended Trading$1.64 0.00 (-0.30%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DCGO vs. CDNA, CSTL, AUNA, INNV, SBC, AGL, TALK, PSNL, AIRS, and EHABShould you be buying DocGo stock or one of its competitors? The main competitors of DocGo include CareDx (CDNA), Castle Biosciences (CSTL), Auna (AUNA), InnovAge (INNV), SBC Medical Group (SBC), Agilon Health (AGL), Talkspace (TALK), Personalis (PSNL), AirSculpt Technologies (AIRS), and Enhabit (EHAB). These companies are all part of the "healthcare" industry. DocGo vs. Its Competitors CareDx Castle Biosciences Auna InnovAge SBC Medical Group Agilon Health Talkspace Personalis AirSculpt Technologies Enhabit CareDx (NASDAQ:CDNA) and DocGo (NASDAQ:DCGO) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, valuation, institutional ownership, analyst recommendations and media sentiment. Do insiders and institutionals have more ownership in CDNA or DCGO? 56.4% of DocGo shares are owned by institutional investors. 4.4% of CareDx shares are owned by insiders. Comparatively, 3.8% of DocGo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media refer more to CDNA or DCGO? In the previous week, CareDx had 5 more articles in the media than DocGo. MarketBeat recorded 11 mentions for CareDx and 6 mentions for DocGo. CareDx's average media sentiment score of 1.07 beat DocGo's score of 0.33 indicating that CareDx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CareDx 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive DocGo 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable valuation & earnings, CDNA or DCGO? CareDx has higher earnings, but lower revenue than DocGo. DocGo is trading at a lower price-to-earnings ratio than CareDx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCareDx$333.79M2.04$52.55M$1.0212.56DocGo$616.55M0.26$19.99M-$0.19-8.68 Is CDNA or DCGO more profitable? CareDx has a net margin of 17.97% compared to DocGo's net margin of -4.20%. CareDx's return on equity of 18.03% beat DocGo's return on equity.Company Net Margins Return on Equity Return on Assets CareDx17.97% 18.03% 12.88% DocGo -4.20%-3.26%-2.24% Which has more volatility and risk, CDNA or DCGO? CareDx has a beta of 2.22, indicating that its stock price is 122% more volatile than the S&P 500. Comparatively, DocGo has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500. Do analysts recommend CDNA or DCGO? CareDx currently has a consensus price target of $27.67, indicating a potential upside of 115.98%. DocGo has a consensus price target of $3.59, indicating a potential upside of 117.58%. Given DocGo's higher probable upside, analysts clearly believe DocGo is more favorable than CareDx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CareDx 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57DocGo 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryCareDx beats DocGo on 13 of the 16 factors compared between the two stocks. Get DocGo News Delivered to You Automatically Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DCGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DCGO vs. The Competition Export to ExcelMetricDocGoMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$161.39M$7.69B$5.74B$9.77BDividend YieldN/A2.69%4.40%4.08%P/E Ratio-8.6878.4130.4126.04Price / Sales0.2649.61428.97104.72Price / Cash4.0725.5525.7828.79Price / Book0.537.619.706.08Net Income$19.99M$242.04M$3.27B$265.64M7 Day Performance3.77%0.02%3.94%3.11%1 Month Performance13.01%-0.71%3.81%0.39%1 Year Performance-55.88%8.50%31.26%18.52% DocGo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DCGODocGo2.0984 of 5 stars$1.65+0.6%$3.59+117.6%-55.9%$161.39M$616.55M-8.684,407CDNACareDx4.2706 of 5 stars$11.85+0.1%$27.67+133.5%-59.6%$630.21M$333.79M11.62740News CoveragePositive NewsAnalyst ForecastCSTLCastle Biosciences2.4288 of 5 stars$20.56+2.3%$37.00+80.0%-30.4%$582.78M$332.07M-58.74540News CoverageAUNAAuna4.0823 of 5 stars$6.27-0.7%$10.70+70.8%-19.7%$467.02M$1.17B10.8014,842Earnings ReportINNVInnovAge2.4099 of 5 stars$3.53+2.9%$5.00+41.6%-42.0%$463.09M$763.85M-15.352,350News CoverageSBCSBC Medical GroupN/A$4.24-4.9%N/AN/A$462.11M$205.42M13.25N/AAGLAgilon Health2.6225 of 5 stars$1.24+11.3%$3.58+189.8%-69.3%$460.01M$6.06B-1.601,076TALKTalkspace3.7562 of 5 stars$2.60+1.6%$4.50+73.1%+49.7%$428.72M$187.59M130.07500PSNLPersonalis4.159 of 5 stars$4.85+5.4%$7.42+52.9%-21.3%$407.91M$84.61M-3.79400AIRSAirSculpt Technologies0.4295 of 5 stars$6.32+1.0%$3.75-40.7%+42.5%$390.54M$180.35M-25.28240EHABEnhabit1.2057 of 5 stars$7.93+4.8%$8.67+9.4%-1.9%$383.22M$1.03B-2.9710,700Positive News Related Companies and Tools Related Companies CDNA Alternatives CSTL Alternatives AUNA Alternatives INNV Alternatives SBC Alternatives AGL Alternatives TALK Alternatives PSNL Alternatives AIRS Alternatives EHAB Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DCGO) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DocGo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access